Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$306.88 - $380.0 $389,737 - $482,600
-1,270 Reduced 2.69%
46,019 $17.4 Million
Q3 2023

Nov 13, 2023

SELL
$315.92 - $397.36 $64,763 - $81,458
-205 Reduced 0.43%
47,289 $15 Million
Q2 2023

Aug 11, 2023

SELL
$346.15 - $392.09 $203,882 - $230,941
-589 Reduced 1.22%
47,494 $18.2 Million
Q1 2023

May 12, 2023

SELL
$323.56 - $373.36 $20,060 - $23,148
-62 Reduced 0.13%
48,083 $18 Million
Q4 2022

Feb 13, 2023

SELL
$248.67 - $334.17 $53,215 - $71,512
-214 Reduced 0.44%
48,145 $15.9 Million
Q3 2022

Nov 14, 2022

BUY
$263.81 - $337.27 $249,828 - $319,394
947 Added 2.0%
48,359 $12.8 Million
Q2 2022

Aug 10, 2022

BUY
$301.4 - $428.42 $7,836 - $11,138
26 Added 0.05%
47,412 $14.8 Million
Q1 2022

May 16, 2022

BUY
$379.46 - $424.54 $2.06 Million - $2.3 Million
5,417 Added 12.91%
47,386 $19.8 Million
Q4 2021

Feb 14, 2022

SELL
$373.53 - $434.12 $17,929 - $20,837
-48 Reduced 0.11%
41,969 $17.6 Million
Q2 2021

Aug 06, 2021

BUY
$372.36 - $412.07 $63,673 - $70,463
171 Added 0.41%
42,017 $16.7 Million
Q1 2021

May 17, 2021

SELL
$357.26 - $392.57 $13,218 - $14,525
-37 Reduced 0.09%
41,846 $16.1 Million
Q4 2020

Feb 16, 2021

SELL
$319.05 - $363.32 $31,266 - $35,605
-98 Reduced 0.23%
41,883 $15.2 Million
Q3 2020

Nov 13, 2020

BUY
$280.08 - $347.78 $182,892 - $227,100
653 Added 1.58%
41,981 $14.2 Million
Q2 2020

Aug 12, 2020

BUY
$270.93 - $320.3 $334,869 - $395,890
1,236 Added 3.08%
41,328 $11.7 Million
Q1 2020

May 13, 2020

BUY
$243.44 - $359.98 $373,680 - $552,569
1,535 Added 3.98%
40,092 $11.1 Million
Q4 2019

Feb 13, 2020

BUY
$281.18 - $322.05 $10.8 Million - $12.4 Million
38,557 New
38,557 $12.4 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Rbo & CO LLC Portfolio

Follow Rbo & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rbo & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rbo & CO LLC with notifications on news.